These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 6230629

  • 21. Aredia: the once-monthly infusion for the treatment of bone metastases.
    Lipton A.
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S1-5. PubMed ID: 9801852
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Osteolytic metastases of breast cancer and biphosphonates].
    Lortholary A, Alleaume C, Pein F, Larra F.
    Rev Med Interne; 1992 Aug; 13(3):238-42. PubMed ID: 1410908
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy.
    Merlini G, Parrinello GA, Piccinini L, Crema F, Fiorentini ML, Riccardi A, Pavesi F, Novazzi F, Silingardi V, Ascari E.
    Hematol Oncol; 1990 Aug; 8(1):23-30. PubMed ID: 2137106
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate.
    Jacobs TP, Siris ES, Bilezikian JP, Baquiran DC, Shane E, Canfield RE.
    Ann Intern Med; 1981 Mar; 94(3):312-6. PubMed ID: 6452846
    [Abstract] [Full Text] [Related]

  • 32. Disodium clodronate in the treatment of pain due to bone metastases.
    Luzzani M, Vidili MG, Rissotto R, Nobile MT, Beghè F, Rosso R, Gottlieb A.
    Int J Clin Pharmacol Res; 1990 Mar; 10(4):243-6. PubMed ID: 2150406
    [Abstract] [Full Text] [Related]

  • 33. Diphosphonates for osteolytic metastases.
    Elomaa I, Blomqvist C, Porkka L, Holmström T, Taube T, Lamberg-Allardt C, Borgström GH.
    Lancet; 1985 May 18; 1(8438):1155-6. PubMed ID: 2860356
    [No Abstract] [Full Text] [Related]

  • 34. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
    Tubiana-Hulin M, Beuzeboc P, Mauriac L, Barbet N, Frenay M, Monnier A, Pion JM, Switsers O, Misset JL, Assadourian S, Bessa E.
    Bull Cancer; 2001 Jul 18; 88(7):701-7. PubMed ID: 11495824
    [Abstract] [Full Text] [Related]

  • 35. [Bone targeting agents: bisphosphonates].
    Debiais F.
    Bull Cancer; 2013 Nov 18; 100(11):1199-206. PubMed ID: 24158668
    [Abstract] [Full Text] [Related]

  • 36. The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer.
    Kylmälä T, Tammela TL, Lindholm TS, Seppänen J.
    Ann Chir Gynaecol; 1994 Nov 18; 83(4):316-9. PubMed ID: 7537482
    [Abstract] [Full Text] [Related]

  • 37. Clodronate and other bisphosphonates as supportive therapy in osteolysis due to malignancy.
    Elomaa I, Blomqvist C.
    Acta Oncol; 1995 Nov 18; 34(5):629-36. PubMed ID: 7546830
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Use of bisphosphonates in patients with metastatic bone disease.
    Berenson JR, Lipton A.
    Oncology (Williston Park); 1998 Nov 18; 12(11):1573-9; discussion 1579-81. PubMed ID: 9834935
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.